IFNA1 and neoplasm: RNA-seq and molecular analysis showed that FBXO44 inhibition activated IFN signaling, enhanced antigen presentation, and stimulated various cytokines and ligands that function to recruit cytotoxic T and natural killer (NK) cells, thereby enhancing tumor cell immunogenicity.